Desq Long
Sign in

Company

Compass Therapeutics, Inc.

CMPX · CIK 0001738021

SEC FORM 4
$2,850.00

Compass Therapeutics, Inc. (CMPX)

Purchase of 2,500 shares at $1.14 per share.

Reporting Person Lerner Neil · Officer Title Chief Accounting Officer · Transaction Code P

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001171843-26-006235 · filed 2026-09-25 · View filing →